Sun Pharma Q3 Net Profit Rises 16% to ₹3,369 Crore on Broad-Based Growth by Economy India February 1, 2026 Sun Pharma Q3 Net Profit Rises 16% to ₹3,369 Crore on Broad-Based Growth
US Tariff to Increase Cost of Indian Goods; Export Competitiveness Hinges on Rival Nations: Exporters
Bank of India Q1 Profit Jumps 81% to ₹3,302.58 Crore; Targets USD 1.2 Billion Through FCNR(B) Deposits